{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:56:21Z","timestamp":1791186981797,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hainan Provincial Natural Science Foundation of China","award":["824RC555"],"award-info":[{"award-number":["824RC555"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05683-y","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T08:02:15Z","timestamp":1786176135000},"page":"4657-4671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GALNT6-glycosylated LRG1 mediates the interaction between M2 macrophages and pancreatic cancer cells by activating CCR1\/PI3K\/AKT axis"],"prefix":"10.1007","volume":"481","author":[{"given":"Dengjian","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexiong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duxiong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"2","key":"5683_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM (2022) Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology 163(2):386-402.e1. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.056","journal-title":"Gastroenterology"},{"issue":"4","key":"5683_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/0115701646317271240821071544","volume":"21","author":"F Jiana","year":"2024","unstructured":"Jiana F, Jingru H, Jiazhong Z, Lin C, Jin D (2024) Comprehensive analysis of tertiary lymphoid structures in pancreatic cancer: molecular characteristics and prognostic implications. Curr Proteomics 21(4):230\u2013250. https:\/\/doi.org\/10.2174\/0115701646317271240821071544","journal-title":"Curr Proteomics"},{"issue":"1","key":"5683_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"HM Kolbeinsson","year":"2023","unstructured":"Kolbeinsson HM, Chandana S, Wright GP, Chung M (2023) Pancreatic cancer: a review of current treatment and novel therapies. J Investig Surg 36(1):2129884. https:\/\/doi.org\/10.1080\/08941939.2022.2129884","journal-title":"J Investig Surg"},{"issue":"8","key":"5683_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, di Magliano MP, Maitra A (2023) Pancreatic cancer: advances and challenges. Cell 186(8):1729\u20131754. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014","journal-title":"Cell"},{"issue":"11","key":"5683_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C (2022) Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov 21(11):799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"5683_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/0118744710336823241011095632","volume":"18","author":"R Fatemeh","year":"2025","unstructured":"Fatemeh R, Pooya H, Fatemeh R, Fariborz M, Fazel G, Alireza N, Leila H, Michael RH, Atousa J, Reza P (2025) Apigenin\u2019s influence on inflammatory and epigenetic responses in rat lungs after radiotherapy. Curr Radiopharmaceuticals 18(2):147\u2013157. https:\/\/doi.org\/10.2174\/0118744710336823241011095632","journal-title":"Curr Radiopharmaceuticals"},{"key":"5683_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni M, Ghosheh Y, Pramod AB, Ley K (2019) Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol 10:1084. https:\/\/doi.org\/10.3389\/fimmu.2019.01084","journal-title":"Front Immunol"},{"key":"5683_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"A Viola","year":"2019","unstructured":"Viola A, Munari F, Sanchez-Rodriguez R, Scolaro T, Castegna A (2019) The metabolic signature of macrophage responses. Front Immunol 10:1462. https:\/\/doi.org\/10.3389\/fimmu.2019.01462","journal-title":"Front Immunol"},{"issue":"1","key":"5683_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M Li","year":"2023","unstructured":"Li M, Yang Y, Xiong L, Jiang P, Wang J, Li C (2023) Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol 16(1):80. https:\/\/doi.org\/10.1186\/s13045-023-01478-6","journal-title":"J Hematol Oncol"},{"key":"5683_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.canlet.2020.10.029","volume":"498","author":"J Yang","year":"2021","unstructured":"Yang J, Li Y, Sun Z, Zhan H (2021) Macrophages in pancreatic cancer: an immunometabolic perspective. Cancer Lett 498:188\u2013200. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.029","journal-title":"Cancer Lett"},{"issue":"1","key":"5683_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00790-6","volume":"29","author":"C Camilli","year":"2022","unstructured":"Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J (2022) LRG1: an emerging player in disease pathogenesis. J Biomed Sci 29(1):6. https:\/\/doi.org\/10.1186\/s12929-022-00790-6","journal-title":"J Biomed Sci"},{"issue":"1","key":"5683_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/MPA.0000000000000205","volume":"44","author":"K Furukawa","year":"2015","unstructured":"Furukawa K, Kawamoto K, Eguchi H, Tanemura M, Tanida T, Tomimaru Y, Akita H, Hama N, Wada H, Kobayashi S, Nonaka Y, Takamatsu S, Shinzaki S, Kumada T, Satomura S, Ito T, Serada S, Naka T, Mori M, Doki Y, Miyoshi E, Nagano H (2015) Clinicopathological significance of Leucine-Rich alpha2-glycoprotein-1 in sera of patients with pancreatic cancer. Pancreas 44(1):93\u201398. https:\/\/doi.org\/10.1097\/MPA.0000000000000205","journal-title":"Pancreas"},{"issue":"1","key":"5683_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jhbp.986","volume":"30","author":"DH Lee","year":"2021","unstructured":"Lee DH, Yoon W, Lee A, Han Y, Byun Y, Kang JS, Kim H, Kwon W, Suh YA, Choi Y, Namkung J, Han S, Yi SG, Heo JS, Han IW, Park JO, Park JK, Kim SC, Jun E, Kang CM, Lee WJ, Lee HK, Lee H, Lee S, Jeong SY, Lee KE, Han W, Park T, Jang JY (2021) Multi-biomarker panel prediction model for diagnosis of pancreatic cancer. J Hepatobiliary Pancreat Sci 30(1):122\u2013132. https:\/\/doi.org\/10.1002\/jhbp.986","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"36","key":"5683_CR14","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/s41388-024-03118-w","volume":"43","author":"Y Song","year":"2024","unstructured":"Song Y, Zhang Y, Wang Z, Lin Y, Cao X, Han X, Li G, Hou A, Han S (2024) CCL2 mediated IKZF1 expression promotes M2 polarization of glioma-associated macrophages through CD84-SHP2 pathway. Oncogene 43(36):2737\u20132749. https:\/\/doi.org\/10.1038\/s41388-024-03118-w","journal-title":"Oncogene"},{"issue":"1","key":"5683_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/01902148.2024.2380988","volume":"50","author":"D Wang","year":"2024","unstructured":"Wang D, Pei W, Liu Y, Mo R, Li X, Gu W, Su Y, Ye J, Xu J, Zhao D (2024) Leucine rich alpha2 glycoprotein 1 derived from malignant pleural mesothelioma cells facilitates macrophage M2 phenotypes. Exp Lung Res 50(1):136\u2013145. https:\/\/doi.org\/10.1080\/01902148.2024.2380988","journal-title":"Exp Lung Res"},{"issue":"1","key":"5683_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hep.30134","volume":"69","author":"LZ Liu","year":"2019","unstructured":"Liu LZ, Zhang Z, Zheng BH, Shi Y, Duan M, Ma LJ, Wang ZC, Dong LQ, Dong PP, Shi JY, Zhang S, Ding ZB, Ke AW, Cao Y, Zhang XM, Xi R, Zhou J, Fan J, Wang XY, Gao Q (2019) CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma. Hepatology 69(1):143\u2013159. https:\/\/doi.org\/10.1002\/hep.30134","journal-title":"Hepatology"},{"issue":"1","key":"5683_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s42003-020-01246-z","volume":"3","author":"V Krishnan","year":"2020","unstructured":"Krishnan V, Tallapragada S, Schaar B, Kamat K, Chanana AM, Zhang Y, Patel S, Parkash V, Rinker-Schaeffer C, Folkins AK, Rankin EB, Dorigo O (2020) Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1. Commun Biol 3(1):524. https:\/\/doi.org\/10.1038\/s42003-020-01246-z","journal-title":"Commun Biol"},{"issue":"4","key":"5683_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13402-019-00446-y","volume":"42","author":"X Yin","year":"2019","unstructured":"Yin X, Han S, Song C, Zou H, Wei Z, Xu W, Ran J, Tang C, Wang Y, Cai Y, Hu Q, Han W (2019) Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells. Cell Oncol (Dordr) 42(4):459\u2013475. https:\/\/doi.org\/10.1007\/s13402-019-00446-y","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"5683_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41374-019-0345-3","volume":"100","author":"X Zhang","year":"2020","unstructured":"Zhang X, Chen L, Dang WQ, Cao MF, Xiao JF, Lv SQ, Jiang WJ, Yao XH, Lu HM, Miao JY, Wang Y, Yu SC, Ping YF, Liu XD, Cui YH, Zhang X, Bian XW (2020) CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1\/2 signaling. Lab Invest 100(4):619\u2013629. https:\/\/doi.org\/10.1038\/s41374-019-0345-3","journal-title":"Lab Invest"},{"key":"5683_CR20","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.redox.2024.103200","volume":"73","author":"X Mao","year":"2024","unstructured":"Mao X, Xu J, Xiao M, Liang C, Hua J, Liu J, Wang W, Yu X, Meng Q, Shi S (2024) ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. Redox Biol 73:103200. https:\/\/doi.org\/10.1016\/j.redox.2024.103200","journal-title":"Redox Biol"},{"issue":"11","key":"5683_CR21","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1111\/cas.70185","volume":"116","author":"Y Xie","year":"2025","unstructured":"Xie Y, Zhou Z, Song J, Wang C, Ding Y, Qiu Y, Fang L, Cheng H (2025) DHCR7 promotes liver metastasis of pancreatic cancer through PI3K-Akt signaling pathway. Cancer Sci 116(11):3196\u20133208. https:\/\/doi.org\/10.1111\/cas.70185","journal-title":"Cancer Sci"},{"issue":"26","key":"5683_CR22","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/onc.2016.515","volume":"36","author":"MHA van Attekum","year":"2017","unstructured":"van Attekum MHA, Terpstra S, Slinger E, von Lindern M, Moerland PD, Jongejan A, Kater AP, Eldering E (2017) Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia. Oncogene 36(26):3651\u20133660. https:\/\/doi.org\/10.1038\/onc.2016.515","journal-title":"Oncogene"},{"issue":"1","key":"5683_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-022-01587-9","volume":"21","author":"J Gu","year":"2022","unstructured":"Gu J, Huang W, Wang X, Zhang J, Tao T, Zheng Y, Liu S, Yang J, Chen ZS, Cai CY, Li J, Wang H, Fan Y (2022) Hsa-miR-3178\/RhoB\/PI3K\/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Mol Cancer 21(1):112. https:\/\/doi.org\/10.1186\/s12943-022-01587-9","journal-title":"Mol Cancer"},{"issue":"4","key":"5683_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.cell.2014.04.016","volume":"157","author":"Y Okabe","year":"2014","unstructured":"Okabe Y, Medzhitov R (2014) Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157(4):832\u2013844. https:\/\/doi.org\/10.1016\/j.cell.2014.04.016","journal-title":"Cell"},{"key":"5683_CR25","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0418","author":"Z Fu","year":"2024","unstructured":"Fu Z, Lai Y, Wang Q, Lin F, Fang J (2024) LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: a bioinformatics study. Endocr Connect. https:\/\/doi.org\/10.1530\/EC-23-0418","journal-title":"Endocr Connect"},{"issue":"10","key":"5683_CR26","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1007\/s12274-023-6268-8","volume":"17","author":"M Chen","year":"2024","unstructured":"Chen M, Zhu A, Zhu F, Lei Z, Huang T, Du S, Wang D, Zhang X, Min H, Qi Y (2024) Identification of LRG1 targeting peptide and its application in targeted imaging for breast cancer. Nano Res 17(10):9044\u20139051. https:\/\/doi.org\/10.1007\/s12274-023-6268-8","journal-title":"Nano Res"},{"issue":"32","key":"5683_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303378","volume":"10","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Guo Y, Liu Y, Ding R, Huang Z, Yu W, Cui L, Du P, Goel A, Liu CY (2023) ELK4 promotes colorectal cancer progression by activating the neoangiogenic factor LRG1 in a noncanonical SP1\/3-dependent manner. Adv Sci 10(32):2303378. https:\/\/doi.org\/10.1002\/advs.202303378","journal-title":"Adv Sci"},{"issue":"3","key":"5683_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10120-022-01279-9","volume":"25","author":"L He","year":"2022","unstructured":"He L, Feng A, Guo H, Huang H, Deng Q, Zhao E, Yang M (2022) LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC\/STAT3\/VEGFA pathway. Gastric Cancer 25(3):527\u2013541. https:\/\/doi.org\/10.1007\/s10120-022-01279-9","journal-title":"Gastric Cancer"},{"key":"5683_CR29","doi-asserted-by":"publisher","DOI":"10.1039\/d4md00940a","author":"Z Lei","year":"2025","unstructured":"Lei Z, Song S, Geng Y, Liu B, Li Y, Min H, Zhang S, Qi Y (2025) The pan-cancer analysis of LRG1 and its potential role in kidney renal clear cell carcinoma. RSC Med Chem. https:\/\/doi.org\/10.1039\/d4md00940a","journal-title":"RSC Med Chem"},{"issue":"1","key":"5683_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.21037\/jgo-21-910","volume":"13","author":"D Cai","year":"2022","unstructured":"Cai D, Chen C, Su Y, Tan Y, Lin X, Xing R (2022) LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling. J Gastrointest Oncol 13(1):400. https:\/\/doi.org\/10.21037\/jgo-21-910","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"5683_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-019-1088-0","volume":"38","author":"Z-B Xie","year":"2019","unstructured":"Xie Z-B, Zhang Y-F, Jin C, Mao Y-S, Fu D-L (2019) LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR\/p38 signaling. J Experimental Clin Cancer Res 38(1):75. https:\/\/doi.org\/10.1186\/s13046-019-1088-0","journal-title":"J Experimental Clin Cancer Res"},{"issue":"21","key":"5683_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218412","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki J, Kojder K, Simi\u0144ska D, Bohatyrewicz R, Gutowska I, Chlubek D, Baranowska-Bosiacka I (2020) CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4. Int J Mol Sci 21(21):8412. https:\/\/doi.org\/10.3390\/ijms21218412","journal-title":"Int J Mol Sci"},{"issue":"29","key":"5683_CR33","doi-asserted-by":"publisher","first-page":"13063","DOI":"10.1073\/pnas.1002372107","volume":"107","author":"T Kitamura","year":"2010","unstructured":"Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, Kizaka-Kondoh S, Aoki M, Taketo MM (2010) Inactivation of chemokine (CC motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci 107(29):13063\u201313068. https:\/\/doi.org\/10.1073\/pnas.1002372107","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"5683_CR34","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1111\/cas.14995","volume":"112","author":"J Meng","year":"2021","unstructured":"Meng J, Wang L, Hou J, Yang X, Lin K, Nan H, Li M, Wu X, Chen X (2021) CCL23 suppresses liver cancer progression through the CCR1\/AKT\/ESR1 feedback loop. Cancer Sci 112(8):3099\u20133110. https:\/\/doi.org\/10.1111\/cas.14995","journal-title":"Cancer Sci"},{"issue":"1","key":"5683_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003131","volume":"10","author":"S Zilio","year":"2022","unstructured":"Zilio S, Bicciato S, Weed D, Serafini P (2022) CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor. J Immunother Cancer 10(1):e003131. https:\/\/doi.org\/10.1136\/jitc-2021-003131","journal-title":"J Immunother Cancer"},{"issue":"22Supplement","key":"5683_CR36","doi-asserted-by":"publisher","first-page":"PR021","DOI":"10.1158\/1538-7445.PANCA22-PR021","volume":"82","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yan W, Brown KL, Velez-Delgado A, Nwosu ZC, Donahue K, Kadiyala P, Yang S, Avritt FR, He X (2022) Abstract PR021: CCR1 expression defines pancreatic tumor associated macrophages and drives their immunosuppressive properties. Cancer Res 82(22Supplement):PR021\u2013PR021. https:\/\/doi.org\/10.1158\/1538-7445.PANCA22-PR021","journal-title":"Cancer Res"},{"key":"5683_CR37","doi-asserted-by":"publisher","first-page":"101722","DOI":"10.1016\/j.bbrep.2024.101722","volume":"38","author":"X Chen","year":"2024","unstructured":"Chen X, Li R, Yin YH, Liu X, Zhou XJ, Qu YQ (2024) Pan-cancer prognosis, immune infiltration, and drug resistance characterization of lung squamous cell carcinoma tumor microenvironment-related genes. Biochem Biophys Rep 38:101722. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101722","journal-title":"Biochem Biophys Rep"},{"issue":"13","key":"5683_CR38","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.2174\/1570180820666230818092456","volume":"21","author":"W Jun","year":"2024","unstructured":"Jun W, Jingjing C (2024) Anti-tumor mechanism of <\u2009i>camellia nitidissima based on network pharmacology and molecular docking. Lett Drug Des Discovery 21(13):2604\u20132617. https:\/\/doi.org\/10.2174\/1570180820666230818092456","journal-title":"Lett Drug Des Discovery"},{"issue":"1","key":"5683_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X (2024) Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Therapy 9(1):194. https:\/\/doi.org\/10.1038\/s41392-024-01886-1","journal-title":"Signal Transduct Target Therapy"},{"key":"5683_CR40","doi-asserted-by":"publisher","first-page":"1097772","DOI":"10.3389\/fonc.2023.1097772","volume":"13","author":"M Ding","year":"2023","unstructured":"Ding M, Liu J, Lv H, Zhu Y, Chen Y, Peng H, Fan S, Chen X (2023) Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-kappaB\/NLRP3\/GSDMD and GSDME signaling pathway. Front Oncol 13:1097772. https:\/\/doi.org\/10.3389\/fonc.2023.1097772","journal-title":"Front Oncol"},{"issue":"5","key":"5683_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41419-020-2537-6","volume":"11","author":"J Song","year":"2020","unstructured":"Song J, Liu W, Wang J, Hao J, Wang Y, You X, Du X, Zhou Y, Ben J, Zhang X (2020) GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78. Cell death disease 11(5):352. https:\/\/doi.org\/10.1038\/s41419-020-2537-6","journal-title":"Cell death disease"},{"issue":"26","key":"5683_CR42","doi-asserted-by":"publisher","first-page":"42588","DOI":"10.18632\/oncotarget.16585","volume":"8","author":"TC Lin","year":"2017","unstructured":"Lin TC, Chen ST, Huang MC, Huang J, Hsu CL, Juan HF, Lin HH, Chen CH (2017) GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity. Oncotarget 8(26):42588\u201342601. https:\/\/doi.org\/10.18632\/oncotarget.16585","journal-title":"Oncotarget"},{"key":"5683_CR43","doi-asserted-by":"publisher","first-page":"111942","DOI":"10.1016\/j.cellsig.2025.111942","volume":"134","author":"S Chong","year":"2025","unstructured":"Chong S, Liu Y, Bian Z, Hu D, Guo S, Dong C, Zeng J, Fan S, Chen X (2025) GALNT6 dual regulates innate immunity STING signaling and PD-L1 expression to promote immune evasion in pancreatic ductal adenocarcinoma. Cell Signal 134:111942. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111942","journal-title":"Cell Signal"},{"issue":"5","key":"5683_CR44","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s12276-023-00992-4","volume":"55","author":"J Yang","year":"2023","unstructured":"Yang J, Yin GN, Kim DK, Han AR, Lee DS, Min KW, Fu Y, Yun J, Suh JK, Ryu JK, Kim HM (2023) Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation. Exp Mol Med 55(5):1013\u20131022. https:\/\/doi.org\/10.1038\/s12276-023-00992-4","journal-title":"Exp Mol Med"},{"issue":"4","key":"5683_CR45","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.3390\/ijms14047923","volume":"14","author":"AK Mu","year":"2013","unstructured":"Mu AK, Lim BK, Hashim OH, Shuib AS (2013) Identification of O-glycosylated proteins that are aberrantly excreted in the urine of patients with early stage ovarian cancer. Int J Mol Sci 14(4):7923\u20137931. https:\/\/doi.org\/10.3390\/ijms14047923","journal-title":"Int J Mol Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05683-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:17Z","timestamp":1791186317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05683-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5683"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05683-y","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by the Ethical Committee of Hainan Medical University (2024-KYL-129).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}